The stock of MetLife, Inc. (NYSE:MET) is a huge mover today! The stock increased 4.42% or $2.02 during the last trading session, reaching $47.73. About 3.00 million shares traded. MetLife, Inc. (NYSE:MET) has declined 0.15% since May 2, 2018 and is downtrending. It has underperformed by 4.52% the S&P500. Some Historical MET News: 24/04/2018 – METLIFE BOOSTS QTR DIV TO $0.42-SHR, FROM $0.40, EST. $0.40; 16/05/2018 – MetLife Names Bill O’Donnell As U.S. Chief Financial Officer; 16/05/2018 – MetLife Launches PlanSmart® Financial Wellness; 02/04/2018 – TBWA’s Lee Clow, Author Seth Godin and MetLife’s Esther Lee Inducted Into American Marketing Association New York Marketing; 03/04/2018 – METLIFE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against MetLife, Inc; 02/05/2018 – METLIFE 1Q ADJ. EPS $1.36, EST. $1.17; 19/03/2018 – ELPRO IN TALKS TO SELL 1.25% STAKE IN PNB METLIFE FOR INR1.25B; 26/04/2018 – MetLife trims compensation for CEO, CFO in year marked by errors; 02/05/2018 – MetLife 1Q Adj EPS $1.36; 08/05/2018 – FEDEX CORP – PURCHASE OF GROUP ANNUITY CONTRACT WILL BE FUNDED DIRECTLY BY ASSETS OF PENSION PLANSThe move comes after 6 months positive chart setup for the $45.43B company. It was reported on May, 2 by Barchart.com. We have $49.64 PT which if reached, will make NYSE:MET worth $1.82 billion more.
Inflarx N.V. (NASDAQ:IFRX) had an increase of 17.35% in short interest. IFRX’s SI was 443,000 shares in May as released by FINRA. Its up 17.35% from 377,500 shares previously. With 109,000 avg volume, 4 days are for Inflarx N.V. (NASDAQ:IFRX)’s short sellers to cover IFRX’s short positions. The SI to Inflarx N.V.’s float is 6.21%. The stock decreased 0.17% or $0.08 during the last trading session, reaching $45.17. About 37,006 shares traded. InflaRx N.V. (NASDAQ:IFRX) has risen 39.39% since May 2, 2018 and is uptrending. It has outperformed by 35.02% the S&P500. Some Historical IFRX News: 29/03/2018 – lnflaRx Full Year 2017 Financial & Operating Results; 08/03/2018 – lnflaRx announces first patient enrolled in Phase llb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 17/05/2018 – InflaRx 1Q Loss EUR10.3M; 29/03/2018 – InflaRx FY Loss/Shr EUR2.6; 03/05/2018 – INFLARX PRIMARY, SECONDARY OFFERINGS PRICES AT $34.00 PER SHARE; 29/03/2018 – InflaRx Full Year 2017 Financial & Operating Results; 17/05/2018 – INFLARX NV – CASH POSITION APPROXIMATELY US$137 MLN (EUR 115 MLN) AS OF MARCH 31, 2018; 17/05/2018 – InflaRx 1Q Loss/Shr EUR0.04; 08/03/2018 InflaRx announces first patient enrolled in Phase IIb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 08/03/2018 – INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE llB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA
Investors sentiment decreased to 0.7 in Q4 2018. Its down 0.16, from 0.86 in 2018Q3. It worsened, as 67 investors sold MetLife, Inc. shares while 340 reduced holdings. 76 funds opened positions while 210 raised stakes. 721.49 million shares or 2.39% less from 739.18 million shares in 2018Q3 were reported. Putnam Invs owns 968,323 shares. Schroder Inv Mngmt reported 144,716 shares stake. Pictet Asset Mngmt Ltd holds 403,156 shares or 0.04% of its portfolio. Stifel Fincl Corp holds 0.14% or 1.04 million shares. Massachusetts-based Rampart Ltd has invested 0.11% in MetLife, Inc. (NYSE:MET). Adirondack Rech & Mngmt Inc has invested 0.24% in MetLife, Inc. (NYSE:MET). 1St Source Comml Bank holds 0.16% of its portfolio in MetLife, Inc. (NYSE:MET) for 39,441 shares. Riggs Asset Managment Company reported 542 shares. City Holdg owns 1,052 shares for 0.01% of their portfolio. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Management invested 0.72% of its portfolio in MetLife, Inc. (NYSE:MET). Amalgamated National Bank owns 0.12% invested in MetLife, Inc. (NYSE:MET) for 106,176 shares. Royal Financial Bank Of Canada holds 0.04% in MetLife, Inc. (NYSE:MET) or 2.18 million shares. Epoch Invest has 1.36% invested in MetLife, Inc. (NYSE:MET) for 7.13M shares. Addenda Capital holds 0.06% or 18,769 shares. Raymond James Assoc invested 0.11% of its portfolio in MetLife, Inc. (NYSE:MET).
Among 5 analysts covering MetLife (NYSE:MET), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. MetLife had 7 analyst reports since November 13, 2018 according to SRatingsIntel. Morgan Stanley maintained it with “Equal-Weight” rating and $54 target in Tuesday, November 13 report. The stock of MetLife, Inc. (NYSE:MET) earned “Buy” rating by Bank of America on Wednesday, January 16. The rating was maintained by Deutsche Bank with “Hold” on Friday, April 12. The stock has “Neutral” rating by UBS on Tuesday, April 9. The firm earned “Outperform” rating on Monday, December 17 by RBC Capital Markets.
More notable recent MetLife, Inc. (NYSE:MET) news were published by: Seekingalpha.com which released: “Wall Street Breakfast: Big Appetite For Beyond Meat IPO – Seeking Alpha” on May 02, 2019, also Benzinga.com with their article: “12 Stocks To Watch For May 1, 2019 – Benzinga” published on May 01, 2019, Seekingalpha.com published: “MetLife declares $0.44 dividend – Seeking Alpha” on April 23, 2019. More interesting news about MetLife, Inc. (NYSE:MET) were released by: Benzinga.com and their article: “Earnings Scheduled For May 1, 2019 – Benzinga” published on May 01, 2019 as well as Investorplace.com‘s news article titled: “3 Big Stock Charts for Monday: Metlife, Wells Fargo and Hormel Foods – Investorplace.com” with publication date: April 15, 2019.
MetLife, Inc., through its subsidiaries, provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. The company has market cap of $45.43 billion. It operates in six divisions: U.S.; Asia; Latin America; Europe, the Middle East, and Africa; MetLife Holdings; and Brighthouse Financial. It has a 9.72 P/E ratio. The firm offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, and critical illness insurance products; vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only and private floating rate funding agreements; and account guaranteed, separate account guaranteed, and trust guaranteed interest contracts.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.